154 related articles for article (PubMed ID: 14615410)
1. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin.
Lugini L; Lozupone F; Matarrese P; Funaro C; Luciani F; Malorni W; Rivoltini L; Castelli C; Tinari A; Piris A; Parmiani G; Fais S
Lab Invest; 2003 Nov; 83(11):1555-67. PubMed ID: 14615410
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic function of ezrin in human metastatic melanomas.
Federici C; Brambilla D; Lozupone F; Matarrese P; de Milito A; Lugini L; Iessi E; Cecchetti S; Marino M; Perdicchio M; Logozzi M; Spada M; Malorni W; Fais S
Int J Cancer; 2009 Jun; 124(12):2804-12. PubMed ID: 19235924
[TBL] [Abstract][Full Text] [Related]
3. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells.
Lugini L; Matarrese P; Tinari A; Lozupone F; Federici C; Iessi E; Gentile M; Luciani F; Parmiani G; Rivoltini L; Malorni W; Fais S
Cancer Res; 2006 Apr; 66(7):3629-38. PubMed ID: 16585188
[TBL] [Abstract][Full Text] [Related]
4. The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells.
Lozupone F; Perdicchio M; Brambilla D; Borghi M; Meschini S; Barca S; Marino ML; Logozzi M; Federici C; Iessi E; de Milito A; Fais S
EMBO Rep; 2009 Dec; 10(12):1348-54. PubMed ID: 19893578
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
[TBL] [Abstract][Full Text] [Related]
6. Deficiencies in collagen phagocytosis by human fibroblasts in vitro: a mechanism for fibrosis?
McCulloch CA; Knowles GC
J Cell Physiol; 1993 Jun; 155(3):461-71. PubMed ID: 8491787
[TBL] [Abstract][Full Text] [Related]
7. Ezrin in primary cutaneous melanoma.
Ilmonen S; Vaheri A; Asko-Seljavaara S; Carpen O
Mod Pathol; 2005 Apr; 18(4):503-10. PubMed ID: 15475929
[TBL] [Abstract][Full Text] [Related]
8. SOCS3 is a modulator of human macrophage phagocytosis.
Gordon P; Okai B; Hoare JI; Erwig LP; Wilson HM
J Leukoc Biol; 2016 Oct; 100(4):771-780. PubMed ID: 27106674
[TBL] [Abstract][Full Text] [Related]
9. Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.
Xu XZ; Garcia MV; Li TY; Khor LY; Gajapathy RS; Spittle C; Weed S; Lessin SR; Wu H
Mod Pathol; 2010 Feb; 23(2):187-96. PubMed ID: 19898426
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis of apoptotic cells by human macrophages: analysis by multiparameter flow cytometry.
Jersmann HP; Ross KA; Vivers S; Brown SB; Haslett C; Dransfield I
Cytometry A; 2003 Jan; 51(1):7-15. PubMed ID: 12500300
[TBL] [Abstract][Full Text] [Related]
11. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.
Massi D; Marconi C; Franchi A; Bianchini F; Paglierani M; Ketabchi S; Miracco C; Santucci M; Calorini L
Hum Pathol; 2007 Oct; 38(10):1516-25. PubMed ID: 17640716
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma.
Döme B; Somlai B; Ladányi A; Fazekas K; Zöller M; Tímár J
Virchows Arch; 2001 Nov; 439(5):628-35. PubMed ID: 11764382
[TBL] [Abstract][Full Text] [Related]
13. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
14. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
15. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Apaf-1 with progression of melanoma.
Mustika R; Budiyanto A; Nishigori C; Ichihashi M; Ueda M
Pigment Cell Res; 2005 Feb; 18(1):59-62. PubMed ID: 15649154
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
[TBL] [Abstract][Full Text] [Related]
18. Selective expression of PNA-binding glycoconjugates by invasive human melanomas: a new marker of metastatic potential.
Doré JF; Berthier-Vergnes O; Zebda N; Bailly M; Thomas L; Bailly C; Cochran AJ
Pigment Cell Res; 1994 Dec; 7(6):461-4. PubMed ID: 7761355
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine factors influencing melanoma progression].
Dobos J
Magy Onkol; 2009 Mar; 53(1):47-50. PubMed ID: 19318326
[TBL] [Abstract][Full Text] [Related]
20. Loss of beta-catenin expression associated with disease progression in malignant melanoma.
Kageshita T; Hamby CV; Ishihara T; Matsumoto K; Saida T; Ono T
Br J Dermatol; 2001 Aug; 145(2):210-6. PubMed ID: 11531781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
